Joaquín Gómez Gómez, Hospital Clínico Universitario Virgen de la Arrixaca, Ctra. Madrid-Cartagena s/n, 30120, El Palmar, Murcia, Spain.
José Barberán, Hospital Universitario HM Montepríncipe, Avda. Montepríncipe 25, 28660 Boadilla del Monte, Madrid, Spain.
Rev Esp Quimioter. 2020 Dec;33(6):430-435. doi: 10.37201/req/101.2020. Epub 2020 Nov 27.
Methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) may complicate the treatment of diabetic foot infections (DFIs). The aim of this study was to determine the risk factors for these pathogens in DFIs.
This was a prospective observational study of 167 consecutive adult patients with DFIs. The diagnosis and severity of DFIs were based on the Infectious Disease Society of America (IDSA) classification system. Multivariate analyses were performed in order to identify risk factors for MRSA and ESBL-E infections.
S. aureus was the most isolated pathogen (n=82, 37.9 %) followed by Escherichia coli (n= 40, 18.5%). MRSA accounted for 57.3% of all S. aureus and 70% of Klebsiella pneumoniae and 25% of E. coli were ESBL producers, respectively. Deep ulcer [OR 8,563; 95% CI (1,068-4,727)], previous use of fluoroquinolones [OR 2,78; 95% CI (1,156-6,685)] and peripheral vasculopathy [OR 2,47; 95% CI (1.068-4.727)] were the independent predictors for MRSA infections; and osteomyelitis [OR 6,351; 95% CI (1,609-25,068)] and previous use of cephalosporins [OR 5,824; 95% CI (1,517-22,361)] for ESBL-E infections.
MRSA and ESBL-E have adquired a great clinical relevance in DFIs. The availability of their risk factors is very convenient to choose the empirical treatment in severe forms.
耐甲氧西林金黄色葡萄球菌(MRSA)和产超广谱β-内酰胺酶肠杆菌科(ESBL-E)可使糖尿病足感染(DFIs)的治疗复杂化。本研究旨在确定 DFIs 中这些病原体的危险因素。
这是一项对 167 例连续成年 DFI 患者的前瞻性观察性研究。DFIs 的诊断和严重程度基于美国传染病学会(IDSA)分类系统。进行了多变量分析以确定 MRSA 和 ESBL-E 感染的危险因素。
金黄色葡萄球菌是最常见的分离病原体(n=82,37.9%),其次是大肠杆菌(n=40,18.5%)。MRSA 占所有金黄色葡萄球菌的 57.3%,肺炎克雷伯菌的 70%和 25%的大肠杆菌为 ESBL 产生菌。深部溃疡[OR 8.563;95%CI(1.068-4.727)]、氟喹诺酮类药物的既往使用[OR 2.78;95%CI(1.156-6.685)]和周围血管病[OR 2.47;95%CI(1.068-4.727)]是 MRSA 感染的独立预测因子;骨髓炎[OR 6.351;95%CI(1.609-25.068)]和头孢菌素类药物的既往使用[OR 5.824;95%CI(1.517-22.361)]是 ESBL-E 感染的独立预测因子。
MRSA 和 ESBL-E 在 DFIs 中具有重要的临床相关性。这些危险因素的存在非常方便选择严重形式的经验性治疗。